![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZNF382 |
Gene summary for ZNF382 |
![]() |
Gene information | Species | Human | Gene symbol | ZNF382 | Gene ID | 84911 |
Gene name | zinc finger protein 382 | |
Gene Alias | KS1 | |
Cytomap | 19q13.12 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q96SR6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
84911 | ZNF382 | PTC05 | Human | Thyroid | PTC | 2.31e-02 | 1.26e-01 | 0.2065 |
84911 | ZNF382 | PTC07 | Human | Thyroid | PTC | 2.29e-02 | 5.21e-02 | 0.2044 |
84911 | ZNF382 | ATC13 | Human | Thyroid | ATC | 2.22e-48 | 7.99e-01 | 0.34 |
84911 | ZNF382 | ATC5 | Human | Thyroid | ATC | 2.24e-42 | 8.57e-01 | 0.34 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ZNF382 | INCAF | Thyroid | ATC | DNMT3A,HIF3A,RSPH9, etc. | 1.01e-01 | ![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF382 | SNV | Missense_Mutation | novel | c.1435C>A | p.Leu479Ile | p.L479I | Q96SR6 | protein_coding | deleterious(0.01) | possibly_damaging(0.546) | TCGA-22-A5C4-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ZNF382 | SNV | Missense_Mutation | novel | c.1313N>T | p.Cys438Phe | p.C438F | Q96SR6 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-33-AASD-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
ZNF382 | SNV | Missense_Mutation | novel | c.977G>C | p.Cys326Ser | p.C326S | Q96SR6 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-33-AASL-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
ZNF382 | SNV | Missense_Mutation | novel | c.238N>A | p.Asp80Asn | p.D80N | Q96SR6 | protein_coding | tolerated(0.52) | benign(0.421) | TCGA-39-5034-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
ZNF382 | SNV | Missense_Mutation | novel | c.1629G>T | p.Lys543Asn | p.K543N | Q96SR6 | protein_coding | tolerated(0.08) | benign(0.038) | TCGA-56-7223-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
ZNF382 | SNV | Missense_Mutation | c.1299N>T | p.Glu433Asp | p.E433D | Q96SR6 | protein_coding | deleterious(0) | benign(0.217) | TCGA-66-2800-01 | Lung | lung squamous cell carcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
ZNF382 | SNV | Missense_Mutation | novel | c.1634N>C | p.Glu545Ala | p.E545A | Q96SR6 | protein_coding | deleterious(0.03) | benign(0.083) | TCGA-79-5596-01 | Lung | lung squamous cell carcinoma | Male | Unknown | III/IV | Unknown | Unknown | SD |
ZNF382 | SNV | Missense_Mutation | novel | c.669N>T | p.Met223Ile | p.M223I | Q96SR6 | protein_coding | tolerated(0.1) | benign(0) | TCGA-85-8580-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF382 | SNV | Missense_Mutation | novel | c.1357N>T | p.Leu453Phe | p.L453F | Q96SR6 | protein_coding | tolerated(0.09) | possibly_damaging(0.879) | TCGA-CQ-7068-01 | Oral cavity | head & neck squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
ZNF382 | SNV | Missense_Mutation | rs772538250 | c.338N>A | p.Arg113Lys | p.R113K | Q96SR6 | protein_coding | tolerated(0.43) | benign(0.003) | TCGA-TN-A7HL-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |